Browse by author
Lookup NU author(s): Megan Clark, Dr Christopher Donnell, Professor Justin DurhamORCiD, Dr Ravikumar Balasubramanian
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020 The British Association of Oral Surgeons and John Wiley & Sons Ltd. Managing orofacial pain can be a daunting prospect for the dentally qualified clinician. This article aims to alleviate some of these concerns by providing guidance when pharmacological intervention may be recommended, alongside their dosing regimens and contraindications. The medications discussed include amitriptyline, nortriptyline, gabapentin, pregabalin, duloxetine, carbamazepine, oxcarbazepine, clonazepam, capsaicin, baclofen, lamotrigine, alpha-lipoic acid, lidocaine hydrochloride and benzydamine hydrochloride. Management of orofacial pain is complex and, hence, often requires the input of specialists in secondary care. While the scope of this guide is aimed chiefly at pharmacological management by secondary care dental prescribers, a holistic approach encompassing all biopsychosocial factors is encouraged. The main take home points have been summarised in a table, aimed for use as a ‘quick reference guide’ during clinic sessions. Other contemporaneous prescribing guides and guidelines should always be used in conjunction with this article as licensing and dosing regimens of medications can be different around the world.
Author(s): Clark MV, Donnell CC, Durham JA, Balasubramaniam R
Publication type: Review
Publication status: Published
Journal: Oral Surgery
Year: 2020
Volume: 13
Issue: 4
Pages: 422-449
Print publication date: 01/11/2020
Online publication date: 27/07/2020
Acceptance date: 06/07/2020
ISSN (print): 1752-2471
ISSN (electronic): 1752-248X
Publisher: Blackwell Publishing Ltd
URL: https://doi.org/10.1111/ors.12542
DOI: 10.1111/ors.12542
